Printer Friendly

BioElectronics Signs Deal to Enter Japanese Market.

Order from YesDTC Holdings is the Single Largest Order in Company History

FREDERICK, Md. -- BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the signing of a contract with YesDTC Holdings, Inc. (YESD.OB) to enter the Japanese market and receipt of the single largest product order and revenue commitment in company history.

Shipments of initial products are expected to begin in the first quarter of 2010 with additional shipments expected throughout the year.

"We are very excited about our entry into the Japanese market as we believe consumers will be highly receptive to our drug-free pain relieving and healing technology," said Arnon Horev, BioElectronics Vice President of Marketing. "The initial order being placed via our Japanese distributor is far and away our single biggest order we have ever received and well into six figures. We plan on recognizing part of this order in Q4:09 with the remaining portions and Q1:10 and Q2:10 and to realize additional revenues through the rest of 2010. The realization of a significant portion of this revenue in Q4:09 will allow us to further strengthen our already strong balance sheet. We welcome YesDTC Holdings to our growing ranks of premium international distributors for our award winning pain relieving and healing products."

"At BioElectronics we are aggressively moving into many international markets," Horev said. "As we have previously indicated, we have major initiatives underway in Latin America, Europe, Canada, and China among other international markets. We are expecting to begin airing television commercials in China during the first quarter of 2010 in support of our marketing efforts in that region and we are preparing to enter the Japanese market through our new distribution partner, YesDTC Holdings."

About BioElectronics Corporation

BioElectronics Corporation is the maker of ActiPatch[R] Therapy, RecoveryRx(TM) Devices, HealFast(TM) Therapy (www.healfasttherapy.com) and the Allay(TM) family of inexpensive, disposable drug-free anti-inflammatory devices. For more information please see http://www.BioElectronicsCorp.com.

About YesDTC Holding, Inc.

YesDTC Holdings, Inc. is a direct to consumer marketing company specializing in direct response television (DRTV) and Internet marketing programs. The Company brings a unique set of skills to this marketplace. YesDTC combines both creative talents and financial acumen to create a total package for direct to consumer marketing programs.
COPYRIGHT 2010 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U5MD
Date:Jan 25, 2010
Words:384
Previous Article:MedAssets to Report its Fourth Quarter and Year-end 2009 Financial Results on Monday, February 22nd Prior to 7:00 am ET.
Next Article:Bill Gates and Amazing Kids! Collaborate to Deliver Insight to Teens and Kids via the Amazing Kids! Online Magazine.


Related Articles
BioElectronics Announces Two New Sales Agreements.
BioElectronics Corporation Announces Distribution Agreement with Ream Surgical of the United Kingdom.
BioElectronics Corporation Announces Distribution Agreement With Barron Medical.
BioElectronics Corporation Announces Singapore and Malaysia Sales.
BioElectronics Corporation Announces Distribution Agreement With TSS Medical of Italy.
BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even.
BioElectronics Corp Aggressively Expands Sales into Middle East.
BioElectronics Corp. Announces $400,000 in New Orders From the Middle East.
BioElectronics Announces Significant Progress in Canadian and International Distribution.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters